PortfoliosLab logoPortfoliosLab logo
ZVSA vs. VOO
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

ZVSA vs. VOO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ZyVersa Therapeutics Inc. (ZVSA) and Vanguard S&P 500 ETF (VOO). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

ZVSA vs. VOO - Yearly Performance Comparison


2026 (YTD)2025202420232022
ZVSA
ZyVersa Therapeutics Inc.
49.70%-87.40%-88.22%-98.36%-93.02%
VOO
Vanguard S&P 500 ETF
-3.66%17.82%24.98%26.32%-3.72%

Returns By Period

In the year-to-date period, ZVSA achieves a 49.70% return, which is significantly higher than VOO's -3.66% return.


ZVSA

1D
0.00%
1M
-23.08%
YTD
49.70%
6M
39.86%
1Y
-65.96%
3Y*
-93.33%
5Y*
10Y*

VOO

1D
0.79%
1M
-4.29%
YTD
-3.66%
6M
-1.41%
1Y
18.17%
3Y*
18.58%
5Y*
11.93%
10Y*
14.14%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ZVSA vs. VOO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ZVSA
ZVSA Risk / Return Rank: 2929
Overall Rank
ZVSA Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
ZVSA Sortino Ratio Rank: 4141
Sortino Ratio Rank
ZVSA Omega Ratio Rank: 4242
Omega Ratio Rank
ZVSA Calmar Ratio Rank: 1313
Calmar Ratio Rank
ZVSA Martin Ratio Rank: 2424
Martin Ratio Rank

VOO
VOO Risk / Return Rank: 6060
Overall Rank
VOO Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
VOO Sortino Ratio Rank: 5757
Sortino Ratio Rank
VOO Omega Ratio Rank: 6161
Omega Ratio Rank
VOO Calmar Ratio Rank: 5959
Calmar Ratio Rank
VOO Martin Ratio Rank: 6969
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ZVSA vs. VOO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ZyVersa Therapeutics Inc. (ZVSA) and Vanguard S&P 500 ETF (VOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ZVSAVOODifference

Sharpe ratio

Return per unit of total volatility

-0.33

1.01

-1.34

Sortino ratio

Return per unit of downside risk

0.53

1.53

-1.01

Omega ratio

Gain probability vs. loss probability

1.07

1.23

-0.16

Calmar ratio

Return relative to maximum drawdown

-0.75

1.55

-2.30

Martin ratio

Return relative to average drawdown

-0.88

7.31

-8.19

ZVSA vs. VOO - Sharpe Ratio Comparison

The current ZVSA Sharpe Ratio is -0.33, which is lower than the VOO Sharpe Ratio of 1.01. The chart below compares the historical Sharpe Ratios of ZVSA and VOO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


ZVSAVOODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.33

1.01

-1.34

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.71

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.79

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.56

0.83

-1.40

Correlation

The correlation between ZVSA and VOO is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

ZVSA vs. VOO - Dividend Comparison

ZVSA has not paid dividends to shareholders, while VOO's dividend yield for the trailing twelve months is around 1.18%.


TTM20252024202320222021202020192018201720162015
ZVSA
ZyVersa Therapeutics Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VOO
Vanguard S&P 500 ETF
1.18%1.13%1.24%1.46%1.69%1.25%1.54%1.88%2.06%1.78%2.02%2.10%

Drawdowns

ZVSA vs. VOO - Drawdown Comparison

The maximum ZVSA drawdown since its inception was -100.00%, which is greater than VOO's maximum drawdown of -33.99%. Use the drawdown chart below to compare losses from any high point for ZVSA and VOO.


Loading graphics...

Drawdown Indicators


ZVSAVOODifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-33.99%

-66.01%

Max Drawdown (1Y)

Largest decline over 1 year

-90.93%

-11.98%

-78.95%

Max Drawdown (5Y)

Largest decline over 5 years

-24.52%

Max Drawdown (10Y)

Largest decline over 10 years

-33.99%

Current Drawdown

Current decline from peak

-100.00%

-5.55%

-94.45%

Average Drawdown

Average peak-to-trough decline

-98.73%

-3.72%

-95.01%

Ulcer Index

Depth and duration of drawdowns from previous peaks

77.32%

2.55%

+74.77%

Volatility

ZVSA vs. VOO - Volatility Comparison

ZyVersa Therapeutics Inc. (ZVSA) has a higher volatility of 28.50% compared to Vanguard S&P 500 ETF (VOO) at 5.34%. This indicates that ZVSA's price experiences larger fluctuations and is considered to be riskier than VOO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


ZVSAVOODifference

Volatility (1M)

Calculated over the trailing 1-month period

28.50%

5.34%

+23.16%

Volatility (6M)

Calculated over the trailing 6-month period

91.02%

9.47%

+81.55%

Volatility (1Y)

Calculated over the trailing 1-year period

197.87%

18.11%

+179.76%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

170.59%

16.82%

+153.77%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

170.59%

17.99%

+152.60%